Impact of letrozol on oocyte quality and IVF success
Not Applicable
Recruiting
- Conditions
- Condition 1: Infertility. Condition 2: Infertility. Condition 3: Infertility. Condition 4: Infertility. Condition 5: Infertility. Condition 6: Infertility.Female infertility associated with anovulationFemale infertility of tubal originFemale infertility of uterine originFemale infertility of other originFemale infertility, unspecifiedEncounter for male factor infertility in female patientN97.0N97.1N97.2
- Registration Number
- IRCT20200328046881N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 220
Inclusion Criteria
Infertile patient that IVF candidate with 40 years old or less
use of antagonist protocol for IVF
Exclusion Criteria
Patient with cancer
Use of IVF protocol except antagonist protocol
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umber of metaphase 2 oocyte. Timepoint: After ovum pick up. Method of measurement: Number of metaphase 2 by counting metaphase 2 oocyte by embryologist.
- Secondary Outcome Measures
Name Time Method Oocyte quality. Timepoint: After ovum pick up. Method of measurement: Based on morphology of different parts of metaphase 2 oocyte which determined by embryologist.;Oocyte maturation rate. Timepoint: After ovum pickup. Method of measurement: Number of metaphase2 oocytes divided to number of picked up oocytes.;Fertilization rate. Timepoint: After injection of sperm to metaphase 2 oocyte. Method of measurement: Number of 2PN divided to number of metaphase 2 oocyte that injected.;Clinical pregnancy rate. Timepoint: After embryo transfer. Method of measurement: Number of pregnancy that confirmed with presence of gestational sac in ultrasonography divided to number of fresh or frozen embryo transfer cycles.